SG10201914058QA - Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells - Google Patents

Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells

Info

Publication number
SG10201914058QA
SG10201914058QA SG10201914058QA SG10201914058QA SG10201914058QA SG 10201914058Q A SG10201914058Q A SG 10201914058QA SG 10201914058Q A SG10201914058Q A SG 10201914058QA SG 10201914058Q A SG10201914058Q A SG 10201914058QA SG 10201914058Q A SG10201914058Q A SG 10201914058QA
Authority
SG
Singapore
Prior art keywords
lgr4
lgr5
development
methods
stem cells
Prior art date
Application number
SG10201914058QA
Other languages
English (en)
Inventor
Denver Lough
Original Assignee
Polarityte Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56078499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201914058Q(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polarityte Inc filed Critical Polarityte Inc
Publication of SG10201914058QA publication Critical patent/SG10201914058QA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813Epithelial cells, e.g. keratinocytes, urothelial cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0625Epidermal cells, skin cells; Cells of the oral mucosa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/003D culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Developmental Biology & Embryology (AREA)
SG10201914058QA 2014-12-02 2015-12-01 Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells SG10201914058QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462086526P 2014-12-02 2014-12-02
US14/954,335 US10926001B2 (en) 2014-12-02 2015-11-30 Methods related to minimally polarized functional units

Publications (1)

Publication Number Publication Date
SG10201914058QA true SG10201914058QA (en) 2020-03-30

Family

ID=56078499

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201914058QA SG10201914058QA (en) 2014-12-02 2015-12-01 Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells
SG11201704502RA SG11201704502RA (en) 2014-12-02 2015-12-01 Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201704502RA SG11201704502RA (en) 2014-12-02 2015-12-01 Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells

Country Status (21)

Country Link
US (7) US10926001B2 (fr)
EP (1) EP3227431A4 (fr)
JP (3) JP6791854B2 (fr)
KR (5) KR20170098844A (fr)
CN (1) CN107250348B (fr)
AU (3) AU2015355187C1 (fr)
BR (1) BR112017011808A2 (fr)
CA (1) CA2969707C (fr)
CO (1) CO2017006640A2 (fr)
CR (1) CR20170296A (fr)
EA (1) EA201791125A1 (fr)
GB (2) GB2549872A (fr)
HK (2) HK1250515A1 (fr)
IL (2) IL252613B (fr)
MX (2) MX2017007243A (fr)
MY (1) MY184931A (fr)
NZ (2) NZ755260A (fr)
PH (1) PH12017501009B1 (fr)
SG (2) SG10201914058QA (fr)
WO (1) WO2016089825A1 (fr)
ZA (1) ZA201703907B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3743125A4 (fr) * 2018-01-26 2022-03-02 Polarityte, Inc. Substrat accélérateur de biomatériau à interface composite
AU2019212976A1 (en) * 2018-01-26 2020-07-23 Polarityte, Inc. Complex living interface-coordinated self-assembling materials (CLICSAM)
FR3082123B1 (fr) 2018-06-07 2020-10-16 Urgo Rech Innovation Et Developpement Pansement cellularise et son procede de fabrication

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040126881A1 (en) * 2002-09-06 2004-07-01 Vincent Ronfard Fibrin cell supports and methods of use thereof
WO2006008009A2 (fr) 2004-07-23 2006-01-26 Bayer Healthcare Ag Agents diagnostiques et therapeutiques pour pathologies associees au gpcr 6 contenant la repetition riche en leucine (lgr6)
WO2006026617A2 (fr) 2004-08-30 2006-03-09 Iken Tissue Therapeutics, Inc. Compositions et procedes pour stimuler la croissance capillaire
WO2007048831A2 (fr) * 2005-10-27 2007-05-03 Coloplast A/S Squelette biodegradable avec materiau de matrice extracellulaire
WO2008008009A1 (fr) 2006-07-13 2008-01-17 St. Jude Medical Ab Gestion d'informations médicales dans un système de concentrateur d'informations concernant le patient
US8366723B2 (en) 2006-08-03 2013-02-05 Rassman Licensing, Llc Hair harvesting device and method with localized subsurface dermal fluid insertion
EP2066787A1 (fr) 2006-09-12 2009-06-10 DKFZ Deutsches Krebsforschungszentrum, Stiftung des Öffentlichen Rechts Culture cellulaire de kératinocytes dans des conditions sans différenciation
GB201111244D0 (en) 2011-06-30 2011-08-17 Konink Nl Akademie Van Wetenschappen Knaw Culture media for stem cells
EP2412800A1 (fr) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Organoïde du foie, ses utilisations et son procédé de culture pour l'obtenir
US9752124B2 (en) 2009-02-03 2017-09-05 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
FI20095355A0 (fi) 2009-04-01 2009-04-01 Helsingin Yliopisto Regeneroituva aktiivinen matriisi ja sen käytöt
TW201110973A (en) 2009-06-25 2011-04-01 Shiseido Co Ltd Methods for screening for anti-graying agents on the basis of AFF-4
US20110130711A1 (en) 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
KR20130041103A (ko) 2010-06-30 2013-04-24 진시 첸 피부조직세포 응집체의 제조방법과 및 그 용도
GB201106395D0 (en) 2011-04-14 2011-06-01 Hubrecht Inst Compounds
AU2012328353B2 (en) 2011-10-27 2017-05-25 Universitat Leipzig Method for deriving melanocytes from the hair follicle outer root sheath and preparation for grafting
JP6186997B2 (ja) 2012-08-07 2017-08-30 日油株式会社 塗布型帯電防止剤
US9655930B2 (en) 2012-10-01 2017-05-23 Aderans Research Institute, Inc. Compositions and methods for producing reconstituted skin
US20140106447A1 (en) 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells
HUE049377T2 (hu) 2013-03-14 2020-09-28 Brigham & Womens Hospital Inc Készítmények és eljárások epiteliális õssejtek expanziójára és tenyésztésére
US9592257B2 (en) 2013-10-11 2017-03-14 MWV Cell, LLC Complete human skin organ generated from culture-expanded cells
CN103550828B (zh) * 2013-10-17 2016-01-27 中国科学院动物研究所 一种基于毛囊干细胞和硅凝胶敷料的皮肤重建方法
TWI548413B (zh) 2014-11-07 2016-09-11 國立臺灣大學 誘導毛囊新生的皮膚萃取物、組合物及其用途

Also Published As

Publication number Publication date
US11596714B2 (en) 2023-03-07
GB201902819D0 (en) 2019-04-17
MX2017007243A (es) 2018-01-25
AU2019240603A1 (en) 2019-10-17
US11266765B2 (en) 2022-03-08
EA201791125A1 (ru) 2018-06-29
NZ755260A (en) 2021-12-24
PH12017501009A1 (en) 2017-12-11
CO2017006640A2 (es) 2017-11-21
AU2015355187A1 (en) 2017-06-29
CN107250348B (zh) 2021-09-03
US11000629B2 (en) 2021-05-11
CN107250348A (zh) 2017-10-13
GB2549872A (en) 2017-11-01
HK1250515A1 (zh) 2018-12-21
AU2015355187C1 (en) 2020-02-20
NZ733433A (en) 2019-08-30
GB2569056A (en) 2019-06-05
US20190046691A1 (en) 2019-02-14
PH12017501009B1 (en) 2017-12-11
AU2023202857A1 (en) 2023-05-25
BR112017011808A2 (pt) 2018-02-27
CR20170296A (es) 2018-01-25
US20230181797A1 (en) 2023-06-15
KR20190111167A (ko) 2019-10-01
JP2017538411A (ja) 2017-12-28
US20160151540A1 (en) 2016-06-02
GB2569056B (en) 2020-01-01
IL287488A (en) 2021-12-01
JP2020182880A (ja) 2020-11-12
KR20210043024A (ko) 2021-04-20
KR20180136587A (ko) 2018-12-24
US20220241464A1 (en) 2022-08-04
US20210322643A1 (en) 2021-10-21
US20180154044A1 (en) 2018-06-07
ZA201703907B (en) 2023-03-29
KR20170098844A (ko) 2017-08-30
KR20180136588A (ko) 2018-12-24
WO2016089825A1 (fr) 2016-06-09
MY184931A (en) 2021-04-30
EP3227431A4 (fr) 2019-01-02
AU2015355187B2 (en) 2019-10-03
US10926001B2 (en) 2021-02-23
HK1245327A1 (zh) 2018-08-24
EP3227431A1 (fr) 2017-10-11
CA2969707A1 (fr) 2016-06-09
US11338060B2 (en) 2022-05-24
CA2969707C (fr) 2019-08-20
JP2019088299A (ja) 2019-06-13
IL287488B2 (en) 2023-06-01
IL252613A0 (en) 2017-07-31
SG11201704502RA (en) 2017-06-29
IL252613B (en) 2021-12-01
AU2019240603B2 (en) 2023-02-09
MX2023001655A (es) 2023-04-24
GB201710646D0 (en) 2017-08-16
JP6791854B2 (ja) 2020-11-25
US20180154043A1 (en) 2018-06-07

Similar Documents

Publication Publication Date Title
EP3396771A4 (fr) Électrolyte pour une pile à électrolyte non aqueux et pile à électrolyte non aqueux dans laquelle ce dernier est utilisé
EP3171445A4 (fr) Solution d'électrolyte non aqueuse et dispositif de stockage d'électricité dans lequel celle-ci est utilisée
PL3261166T3 (pl) Elektrolit do niewodnego ogniwa elektrolitowego i ogniwo z niewodnym elektrolitem, w którym jest on stosowany
IL287488A (en) Methods for the development and use of minimally polarized microaggregate cell units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells
EP3333962A4 (fr) Solution d'électrolyte non aqueux et batterie à électrolyte non aqueux l'utilisant
EP3129465A4 (fr) Compositions d'hydrogel destinées à être utilisées dans l'expansion et la différenciation de cellules
EP3167046A4 (fr) Production et cryopréservation de cellules fucosylées à usage thérapeutique
HK1245401A1 (zh) 鑑定、選擇和使用高治療潛力的t細胞表位
EP3070163A4 (fr) Procédé de préparation de cellule souche pluripotente induite, composition utilisée dans le procédé et utilisations du procédé
EP3151326A4 (fr) Électrolyte non aqueux et dispositif de stockage d'électricité dans lequel celui-ci est utilisé
EP3138399C0 (fr) Composition pour une transplantation d'organe, de tissu, ou de cellules, trousse et procédé de transplantation
EP3723180A4 (fr) Solution & xc9;lectrolytique pour batterie & xc0; & xc9;lectrolyte non aqueux, et batterie & xc0; & xc9;lectrolyte non aqueux mettant en & x152;uvre celui-ci
EP3125352A4 (fr) Électrolyte et dispositif électrochimique
EP3107996A4 (fr) Cellules tscm et leurs procédés d'utilisation
EP3094956A4 (fr) Préparation de cellules, d'agrégats cellulaires, et de fragments de tissus
EP3212213A4 (fr) Méthodes et compositions utilisant des polypeptides gdf15 pour augmenter le nombre de globules rouges sanguins
EP3203835A4 (fr) Procédé et composition pour conservation hypothermique de tissu placentaire
EP3401975A4 (fr) Agent de scellement pour dispositif électrochimique mettant en uvre un électrolyte non aqueux, et composition d'agent de scellement pour dispositif électrochimique
EP3188203A4 (fr) Solution électrolytique et dispositif électrochimique
HK1220135A1 (zh) 胎盤幹細胞治療急性腎損傷的用途
IL269252A (en) Expression constructs and methods for expressing polypeptides in eukaryotic cells
PL3195397T3 (pl) Membrana elektrolitowa do zastosowania w ogniwie elektrochemicznym
PL3126546T3 (pl) Ogniwo elektrochemiczne do elektrolizy wody w postaci cieczy lub pary, sposób wytwarzania i zastosowania
EP3091602A4 (fr) Électrolyte et dispositif électrochimique
EP2970883B8 (fr) Cellules souches placentaires améliorées et leurs utilisations